Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Sobro in connection with the investment in NSS Group
Mandate

Vinge advises Sobro in connection with the investment in NSS Group

January 12, 2023 Real Estate and Construction M&A IT, Telecommunications and Outsourcing Banking and Finance Employment and Benefits Commercial Agreements Data protection and processing of personal data

Vinge advises Sobro in connection with the investment in NSS Group, a leading Nordic supplier of shelter solutions such as halls and tarpaulins.

NSS Group consists of Hallbyggarna Jonsereds (Sweden), Lainapeite (Finland) and IPS Hal & Presenning (Denmark). The group has a turnover of approximately SEK 300m and has 35 employees. NSS Group, with its roots in the 1950s, offers a modern and flexible range of products designed for the harsh Nordic climate and an international concept for logistics and procurement. Its customers are mainly found in the industrial and construction sectors.

Vinge’s team consisted of Johan Winnerblad, Elsie Nassar, Ellinor Wargenbrant and August Ahlin (M&A), Christoffer Nordin and Axel Lennartsson (Commercial Agreements), Karl-Gustaw Tobola (Banking and Financing), Kristoffer Larson (Real Estate and Environmental), Sara Passandideh (Employment), Nicklas Thorgerzon (IT and GDPR), Ian Jonsson (Intellectual Property) and Emelie Schoning (Project and VDR Assistant).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025